Although we still do not completely understand the role of HDAC inhibition in the brain [194], it seems evident that selective pharmacological inhibition of some of the multiple HDAC members is a promising area of research for treating early stages of AD. The gene discussed is HDAC9; the disease is Alzheimer disease.